MMEDF Stock Price, News & Analysis

MMEDF OTC

Company Description

MMEDF (OTC: MMEDF) is a publicly traded biotechnology company in the Health Technology sector.

This page provides a comprehensive overview of MMEDF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

May 5, 2021

—

MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics

April 23, 2021

—

MindMed To Commence Trading on Nasdaq

April 5, 2021

—

MindMed Announces the Publication of New Data on Personalized MDMA Dosing

March 30, 2021

—

MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS

March 29, 2021

—

MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board

management

March 22, 2021

—

MindMed Announces Inclusion in FTSE Russell Indexes

MMEDF has 10 recent news articles. Key topics include management, acquisition, partnership. View all MMEDF news →

SEC Filings

View All

No SEC filings available for MMEDF.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MMEDF Company Profile & Sector Positioning

MMEDF (MMEDF) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the OTC.